Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men. (Q53250512)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 August 2006

Language	Label	Description	Also known as
English	Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men.	scientific article published on 31 August 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

1 reference

based on heuristic

inferred from title

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

3

object named as

Yukio Homma

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

author name string

Kazuki Kawabe

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

Masaki Yoshida

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

Silodosin Clinical Study Group

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

publication date

31 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

98

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

1019-1024

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06448.X

21 January 2018

Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06448.X

21 January 2018

Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06448.X

21 January 2018

Effect of KMD-3213, an alpha1A-adrenoceptor antagonist, on the prostatic urethral pressure and blood pressure in male decerebrate dogs.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06448.X

21 January 2018

Pharmacological evidence of distinct alpha 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06448.X

21 January 2018

Lower urinary tract symptoms/benign prostatic hyperplasia: minimizing morbidity caused by treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06448.X

21 January 2018

Quantification and distribution of α1‐adrenoceptor subtype mRNAs in human vas deferens: comparison with those of epididymal and pelvic portions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06448.X

21 January 2018

The effect of prostatectomy on symptom severity and quality of life

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06448.X

21 January 2018

Lower urinary tract symptoms: what are the implications for the patients?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06448.X

21 January 2018

The effects of SB 216469, an antagonist which discriminates between the alpha 1A-adrenoceptor and the human prostatic alpha 1-adrenoceptor.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06448.X

21 January 2018

Synthesis and pharmacological characterization of 3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e] isoindol-2-yl)ethyl]pyrido-[3',4':4,5]thieno[3,2-d]pyrimidine-2,4 (1H,3H)-dione (A-131701): a uroselective alpha 1A adrenoceptor antag

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06448.X

21 January 2018

In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha1A- vs. alpha1B- and alpha1D-adrenoceptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06448.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2006.06448.X

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

release_kzv2imqbbrcfrdymayhggflym4

1 reference

https://api.fatcat.wiki/v0/release/kzv2imqbbrcfrdymayhggflym4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16945121

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53250512&oldid=1840465695"